Gastrenterology, Centro Hospitalar Universitário de São João, Portugal.
Gastroenterology, Centro Hospitalar Universitário de São João, Portugal.
Rev Esp Enferm Dig. 2022 Oct;114(10):592-598. doi: 10.17235/reed.2021.8347/2021.
gastric inflammatory fibroid polyps constitute only 0.1 % of all gastric polyps. They are usually amenable to resection by snare polypectomy. However, on rare occasions, these lesions may require resection by endoscopic submucosal dissection. This study aimed to evaluate the effectiveness and safety of endoscopic submucosal dissection in the management of gastric inflammatory fibroid polyps not amenable to resection with snare polypectomy.
a retrospective observational study of all consecutive patients who underwent endoscopic submucosal dissection for gastric inflammatory fibroid polyps between January 2011 and December 2020 was performed.
there were nine cases of gastric inflammatory fibroid polyps resected by endoscopic submucosal dissection. Most patients were female (7/9) with a mean age of 62.2 years. All gastric inflammatory fibroid polyps were described as solitary antral subepithelial lesions with a mean diameter of 16.7 mm, which appeared well-circumscribed and homogeneous lesions located at muscularis mucosa and submucosa without deeper invasion on endoscopic ultrasound. All lesions were successfully resected by en bloc and complete resection with free margins obtained in 8/9 specimens. Adverse events were reported in 2/9 cases including one intra-procedural bleeding successfully controlled with hemostatic clips and one aspiration pneumonia that evolved favorably. Mean follow-up duration was 33.7 months and no delayed complications or cases of recurrence were reported.
endoscopic submucosal dissection appears safe and effective for the resection of gastric inflammatory fibroid polyps that present as large subepithelial lesions, if performed by experienced endoscopists after adequate characterization by endoscopic ultrasound, with high rates of technical success and low recurrence rates.
胃炎性纤维瘤性息肉仅占所有胃息肉的 0.1%。它们通常可以通过圈套息肉切除术切除。然而,在极少数情况下,这些病变可能需要通过内镜黏膜下剥离术切除。本研究旨在评估内镜黏膜下剥离术治疗不能通过圈套息肉切除术切除的胃炎性纤维瘤性息肉的有效性和安全性。
对 2011 年 1 月至 2020 年 12 月期间所有接受内镜黏膜下剥离术治疗胃炎性纤维瘤性息肉的连续患者进行了回顾性观察性研究。
有 9 例胃炎性纤维瘤性息肉通过内镜黏膜下剥离术切除。大多数患者为女性(7/9),平均年龄为 62.2 岁。所有胃炎性纤维瘤性息肉均描述为单发的胃窦黏膜下上皮下病变,平均直径为 16.7mm,在内镜超声下表现为边界清楚、均匀的病变,位于黏膜肌层和黏膜下层,无更深层的浸润。所有病变均通过整块和完全切除成功切除,8/9 例标本获得了无肿瘤边缘的完整切除。9 例中有 2 例报告了不良事件,包括 1 例术中出血,用止血夹成功控制,1 例吸入性肺炎,病情好转。平均随访时间为 33.7 个月,无迟发性并发症或复发病例。
对于表现为大的黏膜下病变的胃炎性纤维瘤性息肉,如果由经验丰富的内镜医生在充分进行内镜超声检查后进行,内镜黏膜下剥离术具有较高的技术成功率和较低的复发率,是一种安全有效的治疗方法。